Prot# C25001: A Randomized, Open-Label, Phase 3 Trial of brentuximab vedotin (SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date6/15/126/15/18

Funding

  • ICON Clinical Research, LLC (Prot# C25001)
  • Millennium Pharmaceuticals, Inc (Prot# C25001)